Share this video  

ESMO 2023 | Endometrail cancer patients: global views on genetic counseling and hereditary carcinomas

Jalid Sehouli, MD, Charité Universitätsmedizin Berlin, Germany, discusses a survey conducted to assess the status and understanding of endometrial cancer (EC) among 656 patients across seven countries. The study aimed to emphasize the significance of molecular classification, Lynch syndrome, and hereditary EC in treatment decisions. The survey reveals a notable lack of awareness about genetic backgrounds, particularly concerning conditions like Lynch syndrome. Dr Sehouli stresses the need to empower patients to inquire about genetic factors, similar to the awareness seen with BRCA in breast and ovarian cancers. The survey indicates the necessity to educate both patients and doctors, extending beyond gynecologists and oncologists to include general practitioners, addressing the multi-professional challenge of increasing awareness and promoting genetic consultation in endometrial cancer cases. This interview took place at the European Society for Medical Oncology (ESMO) 2023 Congress in Madrid, Spain.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.